Covered recipient · General Payments record
MARTHA BILBATUA
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2023–2024
$3,645.85
- Reported across 205 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,773.19 | 160 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $522.82 | 25 |
| DEXCOM, INC. | $307.87 | 8 |
| Insulet Corporation | $222.16 | 35 |
| Radius Health, Inc. | $189.03 | 8 |
| Lilly USA, LLC | $188.99 | 12 |
| Abbott Laboratories | $170.22 | 7 |
| Amgen Inc. | $157.82 | 10 |
| Corcept Therapeutics | $131.25 | 12 |
| BETA BIONICS, INC. | $110.84 | 4 |
| CHIESI USA, INC. | $93.35 | 4 |
| MannKind Corporation | $92.50 | 5 |
| SANOFI-AVENTIS U.S. LLC | $85.26 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $61.34 | 3 |
| Medtronic, Inc. | $60.27 | 3 |
| EISAI INC. | $52.13 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $36.59 | 1 |
| Currax Pharmaceuticals LLC | $35.21 | 2 |
| Esperion Therapeutics, Inc. | $33.09 | 2 |
| RECORDATI_RARE_DISEASES_INC. | $32.27 | 2 |
| ABBVIE INC. | $29.10 | 2 |
| IBSA Pharma Inc. | $28.67 | 2 |
| Averitas Pharma Inc. | $25.12 | 1 |
| Ascensia Diabetes Care US Inc. | $21.07 | 1 |
| Enterra Medical, Inc. | $20.20 | 1 |
| Madrigal Pharmaceuticals | $17.30 | 1 |
| CeQur Corporation | $16.98 | 1 |
| Tandem Diabetes Care, Inc. | $16.12 | 1 |
| PFIZER INC. | $15.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (160)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.